https://www.zonebourse.com/cours/action/KALVISTA-PHARMACEUTICALS--32018912/actualite/KalVista-atteint-les-principaux-objectifs-d-un-essai-de-phase-avancee-pour-une-maladie-genetique-45939376/?utm_source=telegram&utm_medium=social&utm_campaign=share